ArticleBlood neoplasia2026

Enhanced efficacy of a specific HDAC3 inhibitor in combination with 5-azacitidine against diffuse large B-cell lymphoma.

Calixte Calaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.